Browsing Centre for Evaluation and Methods by Title
Now showing items 80-99 of 111
-
PREDICTABLE CHANGES IN THE ACCURACY OF HUMAN PAPILLOMAVIRUS TESTS AFTER VACCINATION: REVIEW WITH IMPLICATIONS FOR PERFORMANCE MONITORING IN CERVICAL SCREENING
Vaccination against human papillomavirus (HPV) is changing the performance of cytology as a cervical screening test, but its effect on HPV testing is unclear. We review the effect of HPV16/18 vaccination on the epidemiology ... -
Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
(2023-08)BACKGROUND: Lung cancer is the second most common cancer in incidence and the leading cause of cancer deaths worldwide. Meanwhile, lung cancer screening with low-dose CT can reduce mortality. The UK National Screening ... -
Private Demand for Covid-19 Vaccine: A Contingent Assessment from a Low-and Middle-income Country.
(Brieflands, 2021)This study aimed to estimate Iranian willingness to pay (WTP) for a hypothetical COVID-19 vaccine and its determinants. A cross-sectional online survey was conducted from May 2nd to 20th, 2020 among the general population ... -
Protocol for a prospective study evaluating circulating tumour cells status to predict radical prostatectomy treatment failure in localised prostate cancer patients (C-ProMeta-1)
(BMC, 2023-06-23)Background Treatment decisions in prostate cancer (PCa) rely on disease stratifcation between localised and metastatic stages, but current imaging staging technologies are not sensitive to micro-metastatic disease. ... -
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
(Springer, 2024-03-29)BACKGROUND: The increasing number of studies that generate health state utility values (HSUVs) and the impact of HSUVs on cost-utility analyses make a robust tailored quality appraisal (QA) tool for systematic reviews of ... -
RE1 Financing and Reimbursement for Personalised Medicine - Are WE There YET?
(Elsevier, 2020-12)